Dopa And NotM. Jackson
List of bibliographic references
Number of relevant bibliographic references: 41.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000219 | Monika Pötter-Nerger [Allemagne] ; Martin M. Reich [Allemagne] ; James G. Colebatch [Australie] ; G. Deuschl [Allemagne] ; Jens Volkmann [Allemagne] | Differential Effect of Dopa and Subthalamic Stimulation on Vestibular Activity in Parkinson's Disease |
| 000379 | Lynn Rochester [Royaume-Uni] ; Katherine Baker [Royaume-Uni] ; Alice Nieuwboer [Belgique] ; David Burn [Royaume-Uni] | Targeting Dopa-Sensitive and Dopa-Resistant Gait Dysfunction in Parkinson's Disease: Selective Responses to Internal and External Cues |
| 000945 | Szu-Chia Lai [Taïwan] ; Shih-Ming Jung [Taïwan] ; Padraic Grattan-Smith [Australie] ; Ella Sugo [Australie] ; Yen-Wen Lin [Taïwan] ; Rou-Shayn Chen [Taïwan] ; Chiung-Chu Chen [Taïwan] ; Yah-Huei Wu-Chou [Taïwan] ; Anthony E. Lang [Canada] ; Chin-Song Lu [Taïwan] | Neuronal Intranuclear Inclusion Disease: Two Cases of Dopa-responsive Juvenile Parkinsonism with Drug-induced Dyskinesia |
| 000D87 | Nicola Pavese [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Christoph Scherfler [Royaume-Uni] ; Lisa Cohen [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Paola Piccini [Royaume-Uni] | Nigrostriatal Dysfunction in Homozygous and Heterozygous Parkin Gene Carriers: An 18F-Dopa PET Progression Study |
| 001706 | Astrid Thomas [Italie] ; Laura Bonanni [Italie] ; Angelo Antonini [Italie] ; Paolo Barone [Italie] ; Marco Onofrj [Italie] | Dopa-responsive pseudo-orthostatic tremor in parkinsonism |
| 001853 | Christoph Scherfler [Royaume-Uni] ; Naheed L. Khan [Royaume-Uni] ; Nicola Pavese [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; David J. Brooks [Royaume-Uni] ; Paola P. Piccini [Royaume-Uni] | Upregulation of dopamine D2 receptors in dopaminergic drugnaive patients with Parkin gene mutations |
| 001892 | Anna L. Bartels [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Nir Giladi [Israël] ; Joanna D. Schaafsma [Pays-Bas] ; R. Paul Maguire [Pays-Bas] ; Lammy Veenma [Pays-Bas] ; Jan Pruim [Pays-Bas] ; Yacov Balash [Israël] ; Moussa B. H. Youdim [Israël] ; Klaus L. Leenders [Pays-Bas] | Striatal dopa and glucose metabolism in PD patients with freezing of gait |
| 001A75 | Federico Micheli [Argentine] ; Maria Graciela Cersosimo [Argentine] ; Carlos Zuniga Ramirez [Argentine] | Hereditary spastic paraplegia associated with dopa-responsive Parkinsonism |
| 001D59 | Naheed L. Khan [Royaume-Uni] ; Paola Giunti [Royaume-Uni] ; Mary G. Sweeney [Royaume-Uni] ; Christoph Scherfler [Royaume-Uni] ; Michael O. Brien [Royaume-Uni] ; Paola Piccini [Royaume-Uni] ; Nicholas W. Wood [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6) |
| 002245 | Akio Kikuchi [Japon] ; Atsushi Takeda [Japon] ; Kazuo Fujihara [Japon] ; Teiko Kimpara [Japon] ; Yusei Shiga [Japon] ; Hiroaki Tanji [Japon] ; Makiko Nagai [Japon] ; Hirushi Ichinose [Japon] ; Fumi Urano [Japon] ; Nobuyuki Okamura [Japon] ; Hiroyuki Arai [Japon] ; Yasuto Itoyama [Japon] | Arg(184)his mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa-responsive dystonia with parkinsonism: A case report |
| 003151 | J. Lyytinen [Finlande] ; S. Kaakkola [Finlande] ; S. Ahtila [Finlande] ; P. Tuomainen [Finlande] ; H. Ter V Inen [Finlande] | Simultaneous MAO-B and COMT inhibition in L-dopa-treated patients with Parkinson's disease |
| 003319 | C. Raftopoulos [Belgique] ; S. Dethy ; M. A. Laute ; S. Goldman ; A. B. Naini ; S. Przedborski ; J. Hildebrand | Slow increase of homovanillic acid in cerebrospinal fluid after levodopa administration |
| 003415 | A. Benazzouz [France] ; T. Boraud [France] ; J. Feger [France] ; P. Burbaud [France] ; B. Bioulac [France] ; C. Gross [France] | Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates : A comparison with L-dopa treatment |
| 003484 | J. M. Cooper [Royaume-Uni] ; S. E. Daniel ; C. D. Marsden ; A. H. V. Schapira [Royaume-Uni] | L-dihyroxyphenalanine and complex I deficiency in Parkinson's disease brain |
| 003676 | S. B. Blunt [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. Marsden | Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine |
| 003735 | S. A. Factor [États-Unis] ; W. J. Weiner | Early combination therapy with bromocriptine and levodopa in Parkinson's disease |
| 003737 | J. G. Nutt [États-Unis] ; J. H. Carter ; W. Woodward ; J. P. Hammerstad ; S. T. Gancher | Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions |
| 003753 | B. Pardo [États-Unis] ; M. A. Mena [États-Unis] ; S. Fahn ; J. Garcia De Yebenes | Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line |
| 003794 | M. A. Mena [Espagne] ; B. Pardo ; M. J. Casarejos ; S. Fahn ; J. G. De Yebenes | Neurotoxicity of levodopa on catecholamine-rich neurons |
| 003799 | M. R. Luquin [Espagne] ; O. Scipioni ; J. Vaamonde ; O. Gershanik ; J. A. Obeso | Levopoda-induced dyskinesias in Parkinson's disease : clinical and pharmacological classification |
| 003800 | J.-F. De Saint Victor [France] ; C.-L. Gervason | Levopoda-induced diphasic dyskinesias improved by subcutaneous apomorphine |
| 003801 | M Contin [Italie] ; R. Riva ; P. Martinelli ; A. Baruzzi | Kinetic-dynamic relationship of oral levopoda : possible biphasic response after sequential doses in Parkinson's disease |
| 003804 | F. Stocchi [Italie] ; S. Ruggieri ; A. Carta ; J. Ryatt ; N. Quinn ; P. Jenner ; C. D. Marsden ; A. Agnoli | Intravenous boluses and continuous infusions of L-DOPA methyl ester in fluctuating patients with Parkinson's disease |
| 003812 | M. J. Steiger [Royaume-Uni] ; M. Pires ; F. Scaravilli ; N. P. Quinn ; C. D. Marsden | Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration |
| 003852 | M. J. Steiger ; N. P. Quinn ; C. D. Marsden | Sickness due to levodopa-induced neck dyskinesias in Parkinson's disease |
| 003854 | A. S. Walters ; W. A. Hening ; SUDHANSU CHOKROVERTY | Review and videotape recognition of idiopathic restless legs syndrome |
| 003864 | R. Kurlan [États-Unis] ; M. H. Kim ; D. M. Gash | Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys : assessment with a new rating scale for monkey parkinsonism |
| 003865 | M. J. Steiger ; N. P. Quinn ; B. Toone ; C. D. Marsden | Off-period screaming accompanying motor fluctuations in Parkinson's disease |
| 003885 | L. L. Edwards ; R. F. Pfeiffer ; E. M. M. Quigley ; R. Hofman ; M. Balluff | Gastrointestinal symptoms in Parkinson's disease |
| 003891 | P. Giovannini ; I. Piccolo ; S. Genitrini ; P. Soliveri ; F. Girotti ; G. Geminiani ; G. Scigliano ; T. Caraceni | Early-onset Parkinson's disease |
| 003939 | M. A. Menza ; J. Sage ; E. Marshall ; R. Cody ; R. Duvoisin | Mood changes and on-off phenomena in Parkinson's disease |
| 003943 | S. Boyce ; C. E. Clarke ; R. Luquin ; D. Peggs ; R. G. Robertson ; I. J. Mitchell ; M. A. Sambrook ; A. R. Crossman | Induction of chorea and dystonia in parkinsonian primates |
| 003955 | J. Vaamonde ; M. R. Luquin ; J. A. Obeso | Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease |
| 003972 | A. R. Crossman | A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment |
| 003A07 | E. Pourcher ; A.-M. Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France] | Effects of etybenzatropine and diazepam on Levodopa-induced diphasic dyskinesias in Parkinson's disease |
| 003A08 | E. Mohr ; G. Fabbrini ; J. Williams ; J. Schlegel ; C. Cox ; P. Fedio ; T. N. Chase | Dopamine and memory function in Parkinson's disease |
| 003A09 | Joseph Jankovic [États-Unis] ; K. Schwartz ; C. Vander Linden | Comparison of Sinemet CR4 and standars Sinemet: double blind and long-term open trial in Parkinsonian patients with fluctuations |
| 003A21 | R. F. Pfeiffer ; E. L. Sucha | "On-off"-Induced lethal hyperthermia |
| 003A30 | S. Rose ; P. Jenner ; C. D. Marsden | The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats |
| 003A43 | G. Pezzoli ; S. Tesei ; C. Ferrante ; E. Cossutta ; A. Zecchinelli ; G. Scarlato | Madopar HBS in fluctuating Parkinsonian patients: two-year treatment |
| 003A50 | M. Hietanen ; H. Teravainen | Dementia and treatment with L-dopa in Parkinson's disease |
| This area was generated with Dilib version V0.6.23. |  |